Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Purification of Human β and γ Actin from Budding Yeast

ABSTRACT: To facilitate biochemical studies of human cytoplasmic actins, Saccharomyces cerevisiaestrains were developed that express either human β-actin or γ-actin as their sole actin. Actins purified from these strains have biochemical properties similar to mammalian skeletal muscle α-actin, but display differential binding to some key actin regulators. Mass-spectrometry analysis shows that the human actins made from yeast generally retain their N-terminal methionines, which are modified by acetylation.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human) Oryctolagus Sp. 'rabbit_od' Saccharomyces Cerevisiae (baker's Yeast)

TISSUE(S): Cell Culture, Femoral Muscle

SUBMITTER: Ebbing de Jong

LAB HEAD: Jessica Henty-Ridilla

PROVIDER: PXD040174 | Pride | 2023-04-24

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20221203_BH_RMA.mgf	Mgf
	20221203_BH_RMA.mzML	Mzml
	20221203_BH_RMA.mzid.gz	Mzid
	20221203_BH_RMA.raw	Raw
	20221203_BH_b-actin.mgf	Mgf

Items per page:

1 - 5 of 12

Publications

Purification of human β- and γ-actin from budding yeast.

Haarer Brian K BK Pimm Morgan L ML de Jong Ebbing P EP Amberg David C DC Henty-Ridilla Jessica L JL

Journal of cell science 20230509 9

Biochemical studies of human actin and its binding partners rely heavily on abundant and easily purified α-actin from skeletal muscle. Therefore, muscle actin has been used to evaluate and determine the activities of most actin regulatory proteins but there is an underlying concern that these proteins perform differently from actin present in non-muscle cells. To provide easily accessible and relatively abundant sources of human β- or γ-actin (i.e. cytoplasmic actins), we developed Saccharomyces ...[more]

PMID: 37070275

Similar Datasets

N-terminal processing of beta and gamma actin in human platelets

Project description:Actin is one of the most essential and abundant intracellular proteins, playing an essential physiological role as the major constituent of the actin cytoskeleton. Two cytoplasmic actins, beta- and gamma-actin, are encoded by different genes, but their amino acid sequences differ only by four conservative substitutions at the N-terminus, making it very difficult to dissect their individual regulation in vivo. The majority of actins are N-terminally acetylated, following the removal of N-terminal Met. Here, we analyzed beta and gamma cytoplasmic actin N-termini in different actin preparations.

2023-03-11 | PXD032086 | Pride

N-terminal processing of beta and gamma actin in HAP1 cells

2023-03-11 | PXD031481 | Pride

N-terminal processing of beta and gamma actin in MEF cells

2023-03-11 | PXD032139 | Pride

Naa80 acetylates the actin N-terminus impacting the actin cytoskeleton and cell motility

Project description:Eukaryotic actins undergo several post-translational modifications during their maturation to enable a fully functional cytoskeletal network. A unique N-terminal processing is conserved in the animal kingdom and includes the removal of the first one or two amino acids as well as N-terminal acetylation of the newly exposed acidic N-termini. These events have been known for decades, but the mechanism and function of actin N-terminal acetylation are not well understood due to the lack of information on the catalysing N-terminal acetyltransferase (NAT). Here, we show that NAA80, previously known as NAT6 or FUS-2,is a unique, animal kingdom-specific NAT that exclusively N-terminally acetylates actins. In vitro, the lack of actin N-terminal acetylation impedes the actin polymerization rate due to decreased formin-mediated filament elongation, while the depolymerisation rate is unaffected. Human NAA80 knockout cells display a complete loss of actin N-terminal acetylation and a reorganization of the actin cytoskeleton. We reveal Naa80 as the enzyme that specifically N-terminally acetylates actin the most abundant protein in animal cells, and that this modification controls cellular dynamics and cytoskeletal functions. In this project acetylation of actins was investigated with the use of LC-MS/MS and MS1 quantitation of the Total Ion Current signal.

2018-10-24 | PXD006856 | Pride

RNA-seq, ChIP-seq and ATAC-seq analysis of MKL1 blocked cells during reprogramming

Project description:Actins and regulators of actin dynamics generate contractile forces providing major mechanical and structural support for the cell. Whether and how they actively participate in cell fate control is not clear. Here, we report the actin responsive transcription factor complex MKL1/SRF, the major transcriptional regulator of large numbers of actin cytoskeletal genes, as an important regulator of genomic accessibility and cell fate outcome. Somatic cells with weaker MKL1/SRF activity progress toward pluripotency efficiently while sustained MKL1/SRF activity at a level seen in typical fibroblasts is sufficient to stall cells on their trajectory toward pluripotency. This altered cell fate outcome is associated with an overactive actin cytoskeleton, which connects to chromatin via the LINC complex, preventing its conversion into a relaxed, open conformation that allows sufficient accessibility to pluripotency-inducing transcription factors. Interfering with actin polymerization at appropriate times promotes pluripotency induction. Thus, we reveal a previously unappreciated aspect of cell fate control exerted by the actin based cytoskeletal system.

2019-03-01 | GSE120399 | GEO

naa80 knockout zebrafish tissue proteomics

Project description:Investigation of actin N-terminal acetylation status in zebrafish with knockout alleles for Naa80, the actin N-terminal acetyltransferase.

2024-09-26 | PXD046978 | Pride

Furan warheads for covalent trapping of weak protein-protein interactions: specific cross-linking of thymosin β4 to actin

Project description:We describe furan as a triggerable ‘warhead’ for site-specific cross-linking using the actin and thymosin β4 (Tβ4)-complex as model of a weak and dynamic protein-protein interaction with known 3D structure and with application potential in disease contexts. The presented in vitro validation of covalently acting ‘furan-armed’ Tβ4-variants provides initial proof to further exploit furan-technology for covalent drug design.

2021-05-13 | PXD025066 | Pride

Quality control at the cell surface prevents accumulation of damaged L-type CaV1.2 calcium channels

Project description:Defective ion channel turnover and clearance of damaged proteins are associated with aging and neurodegeneration. The L-type CaV1.2 voltage-gated calcium channel mediate depolarization-induced calcium signals in heart and brain. Here, we determined the interaction surface between the L-type calcium channel CaVβ subunit and actin using cross-linking mass spectrometry and protein-protein docking, and uncovered a role in replenishing damaged CaV1.2 channels. Computational and in vitro mutagenesis identified hotspots in CaVβ that decrease its affinity for actin but not for CaV1.2. Coexpression of an actin-association-deficient CaVβ mutant with the CaV1.2 channel downregulated current amplitudes with a concomitant reduction in the number of functionally available channels. Neither alterations in the single-channel properties nor changes in the total number of channels at the cell surface were found, indicating that current inhibition resulted from a build-up of conduction-defective channels. Our findings established CaVβ–actin interaction as a key player for selective monitoring and clearing corrupted CaV proteins to ensure the maintenance of a functional pool of channels and proper calcium signal transduction. The CaVβ–actin molecular model introduces a potentially druggable protein-protein interface to intervene CaV-mediated signaling processes.

2024-02-16 | PXD044630 | Pride

Quality control at the cell surface prevents accumulation of damaged L-type CaV1.2 calcium channels

2024-02-16 | PXD044723 | Pride

A comparative analysis of genistein and daidzein in affecting lipid metabolism in rat liver

Project description:Effects of soy isoflavones, genistein and daidzein, on the hepatic gene expression profile and indices for lipid metabolism were compared in rats. The GeneChip data was normalized and summarized by using SuperNORM data service (Skylight Biotech Inc.). Significance of expressional change among groups was tested by 2-way ANOVA on the normalized CEL data, which was deposited in a tab-separated ASCII text format. Principal components were identified on the summarized gene data. Three groups of rats were fed with an experimental diet containing 2 g/kg of either genistein or daidzein, or a control diet free of isoflavone for 14 days. The basal composition of the experimental diet was (in g/kg): casein, 200; palm oil, 100; corn starch, 150; cellulose, 20; mineral mixture (AIN-93G), 35; vitamin mixture (AIN-93), 10; L-cystine, 3.0; choline bitartrate, 2.0 and sucrose to 1 kg.

2012-10-10 | E-GEOD-41420 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data